Trial Outcomes & Findings for Treatment Outcomes for Ankle Arthritis (NCT NCT00391365)

NCT ID: NCT00391365

Last Updated: 2026-01-26

Results Overview

Patient reported data using the MFA, a general functional assessment intended as a tool for evaluation of patients' perceptions of their physical, psychological, and social well-being that asks patients to assess their function on 100 items. Number shows change in outcome from pre-op to 3 years by surgery type, with a lower score implying an improved outcome (scale range 0 -100.)

Recruitment status

COMPLETED

Target enrollment

368 participants

Primary outcome timeframe

Over the course of 3 years

Results posted on

2026-01-26

Participant Flow

474 patients were assessed for eligibility with 368 consenting to participate in the study. 95 subjects were excluded for various reasons (no surgery, non-compliant, etc.) resulting in 273 subjects actively participating. 229 subjects successively completed the Year 3 follow-up assessment.

Participant milestones

Participant milestones
Measure
Ankle Arthrodesis (Fusion)
Subjects undergoing ankle arthrodesis (fusion) for treatment of ankle arthritis Gait analysis: Subjects will come into motion analysis laboratory at the VA Puget Sound Health Care System. A standard set of body measurements will be taken using calipers, a measuring tape, and a scale (for example height, weight, leg length, foot length, etc). The investigators will then attach small reflective markers to the body using double-sided tape and ask the participants to walk several times as the motion of each marker is recorded by infrared cameras.
Ankle Arthroplasty (Replacement)
Subjects undergoing ankle arthroplasty (replacement) for treatment of ankle arthritis Gait analysis: Subjects will come into motion analysis laboratory at the VA Puget Sound Health Care System. A standard set of body measurements will be taken using calipers, a measuring tape, and a scale (for example height, weight, leg length, foot length, etc). The investigators will then attach small reflective markers to the body using double-sided tape and ask the participants to walk several times as the motion of each marker is recorded by infrared cameras.
Overall Study
STARTED
103
170
Overall Study
COMPLETED
78
151
Overall Study
NOT COMPLETED
25
19

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Treatment Outcomes for Ankle Arthritis

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Ankle Arthrodesis (Fusion)
n=103 Participants
Subjects undergoing ankle arthrodesis (fusion) for treatment of ankle arthritis Gait analysis: Subjects will come into motion analysis laboratory at the VA Puget Sound Health Care System. A standard set of body measurements will be taken using calipers, a measuring tape, and a scale (for example height, weight, leg length, foot length, etc). The investigators will then attach small reflective markers to the body using double-sided tape and ask the participants to walk several times as the motion of each marker is recorded by infrared cameras.
Ankle Arthroplasty (Replacement)
n=170 Participants
Subjects undergoing ankle arthroplasty (replacement) for treatment of ankle arthritis Gait analysis: Subjects will come into motion analysis laboratory at the VA Puget Sound Health Care System. A standard set of body measurements will be taken using calipers, a measuring tape, and a scale (for example height, weight, leg length, foot length, etc). The investigators will then attach small reflective markers to the body using double-sided tape and ask the participants to walk several times as the motion of each marker is recorded by infrared cameras.
Total
n=273 Participants
Total of all reporting groups
Age, Continuous
57.4 years
STANDARD_DEVIATION 11.4 • n=25 Participants
64.4 years
STANDARD_DEVIATION 9.3 • n=25 Participants
61.76 years
STANDARD_DEVIATION 10.68 • n=50 Participants
Sex: Female, Male
Female
42 Participants
n=25 Participants
81 Participants
n=25 Participants
123 Participants
n=50 Participants
Sex: Female, Male
Male
61 Participants
n=25 Participants
89 Participants
n=25 Participants
150 Participants
n=50 Participants
Region of Enrollment
United States
103 participants
n=25 Participants
170 participants
n=25 Participants
273 participants
n=50 Participants

PRIMARY outcome

Timeframe: Over the course of 3 years

Population: The study started with 103 subjects in the arthrodesis group, and 170 in the arthroplasty group. 78 subjects in the arthrodesis group completed the Year 3 assessment, and 151 in the arthroplasty group. Analysis was done on the MFA data collected from 99 arthrodesis subjects, and 165 arthroplasty subjects.

Patient reported data using the MFA, a general functional assessment intended as a tool for evaluation of patients' perceptions of their physical, psychological, and social well-being that asks patients to assess their function on 100 items. Number shows change in outcome from pre-op to 3 years by surgery type, with a lower score implying an improved outcome (scale range 0 -100.)

Outcome measures

Outcome measures
Measure
Ankle Arthrodesis (Fusion)
n=99 Participants
Subjects undergoing ankle arthrodesis (fusion) for treatment of ankle arthritis
Ankle Arthroplasty (Replacement)
n=165 Participants
Subjects undergoing ankle arthroplasty (replacement) for treatment of ankle arthritis
Musculoskeletal Functional Assessment (MFA)
-12.5 units on a scale
Standard Error 1.4
-15.0 units on a scale
Standard Error 0.9

SECONDARY outcome

Timeframe: Over the course of 3 years.

Population: The study started with 103 subjects in the arthrodesis group, and 170 in the arthroplasty group. 78 subjects in the arthrodesis group completed the Year 3 assessment, and 151 in the arthroplasty group. Analysis was done on the SF-36 physical function data collected from 93 arthrodesis subjects, and 157 arthroplasty subjects.

Patient reported physical function data from the SF-36, a thirty-six item survey evolved from the RAND 36. Change in outcome from pre-op to 3 years by surgery type, with a higher score implying an improved outcome (scale range 0 - 100.)

Outcome measures

Outcome measures
Measure
Ankle Arthrodesis (Fusion)
n=93 Participants
Subjects undergoing ankle arthrodesis (fusion) for treatment of ankle arthritis
Ankle Arthroplasty (Replacement)
n=157 Participants
Subjects undergoing ankle arthroplasty (replacement) for treatment of ankle arthritis
Physical Function Section of Short Form-36 (SF-36)
25.4 units on a scale
Standard Error 2.6
31.8 units on a scale
Standard Error 1.7

SECONDARY outcome

Timeframe: Over the course of 3 years.

Population: The study started with 103 subjects in the arthrodesis group, and 170 in the arthroplasty group. 78 subjects in the arthrodesis group completed the Year 3 assessment, and 151 in the arthroplasty group. Analysis was done on the SF-36 bodily pain data collected from 93 arthrodesis subjects, and 157 arthroplasty subjects.

Patient reported bodily pain data from the SF-36, a thirty-six item survey evolved from the RAND 36. Number shows change in outcome from pre-op to 3 years by surgery type, with a higher score implying an improved outcome (scale range 0 - 100.)

Outcome measures

Outcome measures
Measure
Ankle Arthrodesis (Fusion)
n=93 Participants
Subjects undergoing ankle arthrodesis (fusion) for treatment of ankle arthritis
Ankle Arthroplasty (Replacement)
n=157 Participants
Subjects undergoing ankle arthroplasty (replacement) for treatment of ankle arthritis
Bodily Pain Section of Short Form-36 (SF-36)
35.3 units on a scale
Standard Error 2.9
34.8 units on a scale
Standard Error 2.0

Adverse Events

Ankle Arthrodesis (Fusion)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Ankle Arthroplasty (Replacement)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Alan Wesley, Program Manager

Center For Limb Loss Prevention and Prosthetic Engineering, VA Puget Sound Health Care System

Phone: 206 277 1079

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place